09 Lung Cancer Brochure.indd - Abramson Cancer Center

Abramson Cancer Center 

Second Annual 

EDUCATIONAL CONFERENCE 

Focus On 

Lung Cancer 

& Related Disorders 

For at Risk: Lung Cancer and Related Disorders 

For Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, 

Mesothelioma and Related Disorders 

Friday, October 23, 2009 

8:00 AM - 3:00 PM 

HILTON HOTEL | 4200 CITY AVENUE | PHILADELPHIA, PA

Focus On 

SECOND ANNUAL 

Lung Cancer 

& Related Disorders 

Registration 

To Register or for more information 

800-789-PENN (7366) 

or Register On-Line at 

oncolink.org/conference/lung 

Registration Deadline: Monday, October 19, 2009 

Conference is free of charge. 

No registration fee required. 

$20 Suggested donation (non-tax deductible) 

to support the Focus on Lung Cancer Conference. 

Cash, check or money order accepted the day of the conference. 

Credit cards accepted with our on-line registration. 

Hotel 

Self-parking is available at the Hilton and will be validated. 

For directions to the Hilton Hotel on City Avenue, call 215-879-4000. 

If you need overnight accommodations call Randy Schaller 

at 215-879-3399. 

Please join us for the 2nd Annual Focus on Lung Cancer 

and Related Disorders Conference, where we’ll address 

the needs of those living with or at risk for lung cancer or 

related disorders. 

Our team of experts designed this conference with you and 

your family in mind. You’ll get the latest information and the 

answers to your questions. 

Who Should Attend 

• If you are at risk for: 

~ Lung Cancer 

~ Mesothelioma or related disorders 

• If you are newly diagnosed, currently in treatment 

or a long-term survivor of: 

~ Non-Small Cell Lung Cancer 

~ Small-Cell Lung Cancer 

~ Mesothelioma 

• If you are a: 

~ Family member 

~ Caregiver 

The Focus on Lung Cancer Conference 

is being held in collaboration with PENN Medicine 

Development. Attendees will receive communication 

regarding the lung cancer program, Abramson Cancer 

Center, and other topics. Participation in the conference 

is optional and privacy has been maintained. If you would 

prefer not to receive development materials, please write 

to Abramson Cancer Center Development Offi ce, 

3535 Market Street, Suite 750, Philadelphia, PA 19104. 

Doctors Tracey Evans, 

Corey Langer, 

John Kucharczuk, 

Ramesh Rengan 

and Joel Cooper. 

1

Focus On Lung Cancer and Related Disorders 

Agenda 

REGISTRATION 

8:00 AM 

Ask the Experts Session Sign-up 

Continental Breakfast/Visit Exhibits 

WELCOME 

8:30 AM 

Conference Co-Chairs 

Joel Cooper, MD Ramesh Rengan, MD, PhD 

Corey Langer, MD Daniel Sterman, MD 

Craig Thompson, MD - Director, Abramson Cancer Center 

Joseph Carver, MD - Chief of Staff, Abramson Cancer Center 

GENERAL SESSION 

8:45 AM 

Lung Cancer and Related Disorders Research and Treatment: 

What’s On The Horizon 

With knowledge gained from mapping the human genome, we can 

now target the genes and pathways that are involved in turning normal 

cells into cancer cells. We are on the brink of possessing advanced 

technologies waiting to be adapted to benefi t patients, while we 

continue to pioneer new treatments such as targeted therapies 

and proton radiation treatment. 

Joel Cooper, MD Ramesh Rengan, MD, PhD 

Corey Langer, MD Daniel Sterman, MD 

Health Care Reform Briefing 

Joseph Carver, MD 

News From Capitol Hill: Legislative Priorities for Lung Cancer 

Laurie Fenton Ambrose, President & CEO, Lung Cancer Alliance 

10:00 AM 

Break / Visit Exhibits 

10:15 AM 

Concurrent Sessions: Latest Advancements 

Choose ONE workshop session tailored to your needs 

For Those at Risk 

Get important information on risk factors, monitoring, healthy living 

and the latest research on prevention, and smoking cessation. 

Anil Vachani, MD - Pulmonary 

Joel Cooper, MD - Thoracic Surgery 

Robert Schnoll, PhD - Tobacco Research 

For Survivors of Lung Cancer and Related Disorders 

Get the latest on: diagnosis, treatment, research and clinical trials 

including new technologies coming to Penn - such as proton therapy. 

Non-Small Cell Lung Cancer – Early Stage 

Morris Swartz, MD – Pulmonary 

Taine Pechet, MD – Thoracic Surgery 

Corey Langer, MD – Medical Oncology 

Alexander Lin, MD – Radiation Oncology 

Non-Small Cell Lung Cancer – Locally Advanced 

Andrew Haas, MD, PhD – Pulmonary 

John Kucharczuk, MD – Thoracic Surgery 

Tracey Evans, MD – Medical Oncology 

Ramesh Rengan, MD, PhD – Radiation Oncology 

Non-Small Cell Lung Cancer – Advanced 

Colin Gillespie, MD – Pulmonary 

Jared Weiss, MD – Medical Oncology 

Smith Apisarnthanarax, MD – Radiation Oncology 

Joseph Straton, MD, MSCE – Symptom Management 

Small Cell Lung Cancer 

Steven Albelda, MD – Pulmonary 

Kenneth Algazy, MD – Medical Oncology 

John Christodouleas, MD, MPH - Radiation Oncology 

Mesothelioma and Related Disorders 

Daniel Sterman, MD – Pulmonary 

Joseph Friedberg, MD – Thoracic Surgery 

James Stevenson, MD – Medical Oncology 

Keith Cengel, MD, PhD – Radiation Oncology 

12:00 PM 

Lunch / Ask the Experts Sessions (details on page 4) 

AFTERNOON GENERAL SESSION 

2:00 PM 

Concurrent Sessions 

For Those at Risk 

Coping When You Are at Risk 

Practical strategies for dealing with the challenges of being at risk. 

Topics include: dealing with uncertainty, smoking cessation, 

communicating with loved ones and more. 

Margaret Lazar, MS, MSW, LCSW 

For Survivors 

Survivor Stories: Personal Insights from Lung Cancer Survivors 

Every survivor knows something that can benefi t another. Our diverse 

panel will provide inspiration and hope by sharing their personal stories. 

2 

Moderator: Hope Kushner, MEd 

3


Ask The Experts 

12:00 PM - 2:00 PM 

Time is limited! Please sign up at individual tables 

in the Registration Area! 

SMALL GROUP 

Living with Advanced Cancer 

Nutrition, Herbs & Vitamins 

ONE-ON-ONE 

Clinical Trials 

Cancer Rehabilitation 

Coping with Emotions 

and Caregiver Issues 

Coping with Body Image 

and Sexuality Concerns 

Employment and 

Insurance Concerns 

Financial Planning 

Home Care and 

Symptom Management 

Giving Back 

Integrative Medicine 

• Acupuncture 

• Reiki 

• Yoga & Meditation 

Managing Symptoms 

from Chemotherapy 


from Radiation Treatment 


from Surgery 

Smoking Cessation 

and Environmental Issues 

Your Medications 

• Chemotherapy 

• Prescription Medications 

• Over the Counter Drugs 

EXPERT 

Hope Kushner, MEd 

Katrina Claghorn, MS, RD, CSO, LDN 

EXPERT 

Patricia Madison, RN 

Melissa Culligan, RN, BSN, CCRC 

Elizabeth Reimet, MD 

Kava Schafer, MDiv, MA 


Greg Heller, Esq 

Rodney Warner, Esq 

Andrew Cohen, AIF 

Joseph Straton, MD, MSCE 

Tricia Bruning 

Donna Griffi th 

Jun Mao, MD, MSCE 

Kimberly Fleisher, RMT, Med 

Fern Nibauer-Cohen 

Suzanne Walker, CRNP, MSN, AOCN 

Beth Eaby CRNP, OCN 

Virginia Girard, RN 

Patricia Abbott, PA-C 

Carolyn Vachani, MSN, RN, AOCN 

Robert Schnoll, PhD 

Andrew Strasser, PhD 

Michael Vozniak, PharmD, BCOP 

Conference Co-Chairs 

Joel Cooper, MD 

Professor, Surgery (Thoracic Surgery) 

Chief, Division of Thoracic Surgery, 

University of Pennsylvania 

Health System 

Corey Langer, MD 

Professor, Medicine 

(Hematology/Oncology) 

Director, Thoracic Oncology 

Faculty 

from the Abramson Cancer Center 

Patricia Abbott, PA-C 

Physician Assistant (Thoracic Surgery) 

Steven Albelda, MD 


(Pulmonary and Critical Care) 

Kenneth Algazy, MD 

Clinical Professor, Medicine 


Smith Apisarnthanarax, MD 

Assistant Professor, 

Radiation Oncology 

Tricia Bruning 

Executive Director, Development 

Joseph Carver, MD 


Chief of Staff, Abramson Cancer Center 

Keith Cengel, MD, PhD 

Assistant Professor, Radiation Oncology 

John Christodouleas, MD, MPH 


Katrina Claghorn, MS, RD, CSO, LDN 

Clinical Dietician Specialist 

Patient and Family Services 

Ramesh Rengan, MD, PhD 


Radiation Oncology 

Daniel Sterman, MD 

Associate Professor, Medicine 

Director, Interventional 

Pulmonary Services 

Melissa Culligan, RN, BSN, CCRC 

Clinical Nurse (Thoracic Surgery) 

Beth Eaby, CRNP, OCN 

Advanced Practice Nurse 

Tracey Evans, MD 


Medicine (Hematology/Oncology) 

Joseph Friedberg, MD 

Associate Professor Surgery 

(Thoracic Surgery) 

Chief, Division of Thoracic Surgery, 

Penn Presbyterian Medical Center 

Colin Gillespie, MD 

Instructor, Medicine (Pulmonary) 

Director of Education, 

Interventional Pulmonary Services 

Virginia Girard, RN 

Clinical Nurse, Radiation Oncology 

Donna Griffith 

Director, Volunteer Services 

Andrew Haas, MD, PhD 

Assistant Professor, Medicine 

(Interventional Pulmonary Services) 

John Kucharczuk, MD 

Assistant Professor, Surgery 

(Thoracic Surgery) 

4 5


Faculty continued 

Hope Kushner, MEd 

Patient Support Specialist, 

Patient and Family Services 


Director, Patient and Family Services 

Alexander Lin, MD 


Patricia Madison, RN 

Clinical Research Nurse 


Jun Mao, MD 

Assistant Professor, Family Medicine 

and Community Health 

Fern Nibauer-Cohen 

Associate Director, 

Strategic Marketing Services 

Certifi ed Yoga Instructor 

Taine Pechet, MD 

Assistant Professor 

Surgery (Thoracic Surgery) 

Elizabeth Reimet, MD 


Rehabilitation Medicine 

Director, Cancer Rehabilitation 

Kava Schafer, MDiv, MA 

Staff Oncology Chaplain 

Robert Schnoll, PhD 

Associate Professor, Psychiatry 

Daniel Sterman, MD 

Associate Professor, Medicine 

Director of Interventional Pulmonology 

James Stevenson, MD 



Andrew Strasser, PhD 

Assistant Professor, Psychiatry 

Joseph Straton, MD, MSCE 


Family Medicine & Community Health 

Morris Swartz, MD 

Clinical Associate Professor, 

Medicine (Pulmonary) 

Medical Director, Respiratory Care 

and Pulmonary Diagnostic Services, 

Penn Presbyterian Medical Center 

Craig Thompson, MD 

Professor, 


Director, Abramson Cancer Center 

Anil Vachani, MD 


Medicine (Pulmonary) 

Carolyn Vachani, MSN, RN, AOCN 

Nurse Educator, OncoLink 

Michael Vozniak, PharmD, BCOP 

Oncology Pharmacist 

Suzanne Walker, CRNP, MSN, AOCN 

Advanced Practice Nurse 

Jared Weiss, MD 

Senior Fellow, Medicine 


The Abramson 

Cancer Center 

thanks the following educational grant 

providers for their generous support 

Genentech 

OSI Pharmaceuticals 

About the 


PennMedicine.org/Abramson 

The Abramson Cancer Center of the University of Pennsylvania is 

one of a select group of cancer centers in the country awarded the 

prestigious designation of Comprehensive Cancer Center by the 

National Cancer Institute. This status refl ects our outstanding 

research, clinical services, education and information services, 

and community outreach. 

As part of the University of Pennsylvania Health System, we are able 

to build upon the resources of one of the nation’s foremost medical 

centers, enabling us to address all of our patients’ medical needs. 

We are committed to treating each patient as our only patient, while 

pursuing our understanding of, and ability to fi ght cancer. 

Guest Speakers/Experts 

Laurie Fenton Ambrose 

President & CEO, Lung Cancer Alliance 

Andrew Cohen, AIF 

Vice President, Vantage Point Financial 

Services, Inc 

Greg Heller, Esq 

Caldwell and Heller, LLC 

Rodney Warner, Esq 

Project Attorney, Law and Health 

Initiative for Cancer Survivors, 

Legal Clinic for the Disabled, Inc. 

Penn Medicine’s 

Kimberly Fleisher, RMT, Med 

Perelman Center 

Director, Reiki School and Clinic 

for Advanced Medicine, 

6 

Reiki Practitioner/Teacher 

home to the Abramson Cancer Center 

7


Penn’s Lung Cancer 

Program 

The Penn Difference 

Innovative Research...Advanced Medicine... 

Service Excellence 

Penn created a new level of lung cancer care when it established the 

Center for Lung Cancer and Related Disorders in 1991. The program 

is distinguished in a number of ways including: 

• Dedicated specialists who evaluate and treat only lung disease. 

• Ranked among the top ten by US News and World Report 

for respiratory diseases. 

• A Tobacco and Environmental Carcinogenesis Program that 

is studying the relationships between environmental exposures 

and cancer, with a focus on prevention of tobacco and 

asbestos-related cancers including lung cancer, head and 

neck cancer and mesothelioma. 

• A Tobacco Use Research Center (TTURC) whose mission is to 

understand the factors that infl uence risk for nicotine dependence 

and develop better treatments to help smokers quit. 

• Penn interventional pulmonologists who are using a new minimally 

invasive technology as a less invasive way to stage lung cancer. 

• Penn thoracic surgeons who see more thoracic patients 

than any other hospital in the Delaware Valley. 

• Penn’s thoracic surgeons who were among the fi rst to form a 

separate section specializing in non-cardiac thoracic surgery, 

thus focusing their time and talents on thoracic disorders. 

• Penn thoracic oncologists who have developed new surgical 

procedures to treat previously inoperable lung cancer. 

• Penn clinicians and researchers who developed the nation’s fi rst 

Comprehensive Multispecialty Photodynamic Therapy (PDT) Center. 

• A rate for lung conserving procedures that is among the best 

in the country, ensuring that you will retain the highest quality 

of life possible. 

Lung Cancer Research 

Our extensive research efforts make us one of the most 

comprehensive lung cancer programs in the country. 

Research Highlights 

• We are the leaders in an international effort to revolutionize the 

prevention and management of lung cancer through the creation 

of the fi rst international lung cancer registry, that will deepen our 

understanding of lung cancer. 

• Penn has developed a treatment for mesothelioma based on work 

in the laboratory and continues to test its effectiveness through a 

National Cancer Institute grant. 

• Penn investigators are conducting exciting clinical trials including: 

~ Combination chemotherapy/surgery/radiation for mesothelioma 

~ Autologous tumor vaccine for lung cancer and mesothelioma 

~ PDT for treating currently untreatable tumors 

~ Cell manipulation to enhance immune response 

for lung cancer, and mesothelioma 

~ Lung gene research including: effects of gene expression, 

effect of drugs on inactivated gene, survival as function 

of gene status and vascular invasion. 

• Personalized medicine research on smoking cessation including: 

~ The use of genetic markers to predict an individual smokers’ 

chances of quitting smoking with particular medications. 

~ Brain imaging research that explains why some smokers are 

prone to concentration and memory problems when they try 

to quit smoking. 

~ Evaluation of a blood test that may help doctors make 

decisions about the optimal type, dose and duration 

of treatment for individual smokers. 

Dr. Craig Thompson, Director of the 

• We are a major center for lung cancer clinical trials, allowing us 

Abramson Cancer Center and Dr. Tullia 

8 

to provide some of the newest and best therapies to our patients. 

Lindsten, Research Associate Professor 

9

Life After Lung Cancer 

Conference 


3400 Spruce Street 

1620 Penn Tower 

Philadelphia, PA 19104 

PRESORTED 

First Class 

U.S. Postage 

PAID 

Permit No. 2563 

Phila., PA 19104

09 Lung Cancer Brochure.indd - Abramson Cancer Center

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?